ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 1 filers reported holding ZAI LAB LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -11.8% | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $17 | -99.3% | 600 | -99.2% | 0.00% | -100.0% |
| Q1 2023 | $2,413 | +44.5% | 72,547 | +33.4% | 0.00% | 0.0% |
| Q4 2022 | $1,670 | -100.0% | 54,400 | -63.3% | 0.00% | -83.3% |
| Q3 2022 | $5,063,000 | -44.4% | 148,032 | -43.6% | 0.01% | 0.0% |
| Q2 2022 | $9,101,000 | +53.9% | 262,416 | +95.1% | 0.01% | +20.0% |
| Q1 2022 | $5,914,000 | +240.9% | 134,486 | +536.5% | 0.01% | +400.0% |
| Q2 2020 | $1,735,000 | +316.1% | 21,129 | +160.9% | 0.00% | – |
| Q1 2020 | $417,000 | +187.6% | 8,100 | +131.8% | 0.00% | – |
| Q4 2019 | $145,000 | +10.7% | 3,495 | -13.7% | 0.00% | – |
| Q3 2019 | $131,000 | +469.6% | 4,051 | +496.6% | 0.00% | – |
| Q2 2019 | $23,000 | -64.6% | 679 | -75.7% | 0.00% | – |
| Q4 2018 | $65,000 | – | 2,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
| Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
| INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
| HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
| EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
| Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
| Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
| Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |